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Abstract
Background: India is experiencing an epidemic of obesity-hyperglycaemia, which coincides with child bearing age
for women. The epidemic can be sustained and augmented through transgenerational transmission of adiposity
and glucose intolerance in women. This presents an opportunity for exploring a clear strategy for the control of this
epidemic in India. We conducted a study between November 2013 and May 2015 to inform the design of a large
pregnancy cohort study. Based on the findings of this pilot, we developed the protocol for the proposed birth
cohort of 5000 women, the recruitment for which will start in April 2016. The protocol of the study documents the
processes which aim at advancing the available knowledge, linking several steps in the evolution of obesity led
hyperglycemia.
Methods: Maternal Antecedents of Adiposity and Studying the Transgenerational role of Hyperglycemia and Insulin
(MAASTHI) is a cohort study in the public health facilities in Bangalore, India. The objective of MAASTHI is to
prospectively assess the effects of glucose levels in pregnancy on the risk of adverse infant outcomes, especially in
predicting the possible risk markers of later chronic diseases. The primary objective of the proposed study is to
investigate the effect of glucose levels in pregnancy on skinfold thickness (adiposity) in infancy as a marker of
future obesity and diabetes in offspring. The secondary objective is to assess the association between psychosocial
environment of mothers and adverse neonatal outcomes including adiposity. The study aims to recruit 5000
pregnant women and follow them and their offspring for a period of 4 years. The institutional review board at The
Indian Institute of Public Health (IIPH)-H, Bangalore, Public Health Foundation of India has approved the protocol.
All participants are required to provide written informed consent.
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Discussion: The findings from this study may help to address important questions on screening and management
of high blood sugar in pregnancy. It may provide critical information on the specific determinants driving the
underweight-obesity-T2DM epidemic in India. The study can inform the policy regarding the potential impact of
screening and management protocols in public healthcare facilities. The public health implications include
prioritising issues of maternal glycemic control and weight management and better understanding of the lifecourse
determinants in the development of T2DM.
Keywords: Gestational diabetes, Hyperglycemia, Obesity, Birth cohort, Protocol, Lifecourse epidemiology
Background
India is facing an epidemic of Type II Diabetes Mellitus
(T2DM) with 69.2 million people with diabetes in 2015
[1]. This prevalence rate is projected to increase to 87
million in 2030. [2] T2DM affects Indians earlier than
developed countries, [2–7] and yet there is limited
research to elucidate the causal mechanisms. Part of this
high burden may be explained by programming of
T2DM and obesity ensuing in early life [8–12]. Hyper-
glycemia in pregnant women may alter the intrauterine
environment, thereby increasing the risk of obesity in
childhood and their future risk of diabetes.[2, 12–19]
With an estimated 16.9 % of pregnant women affected
[13], approximately 6 million women might be suffering
from hyperglycemia in pregnancy in India [1, 20]. The
severity and form of maternal hyperglycemia may have a
distinct role in the development of childhood obesity
and T2DM in adult life [19, 21–23]. It is important to
recognize the specific deleterious outcomes which may
manifest in children, including effects of maternal carbo-
hydrate intolerance at all levels including near normal
levels [16, 24–27]. Understanding this pathway could
help address the underweight and gestational hypergly-
cemia led obesity epidemic in low- and middle-income
countries (LMICs) like India.
Hyperglycemia and Adverse Pregnancy Outcome
(HAPO) study confirmed the link between maternal glu-
cose and neonatal adiposity and suggested that the rela-
tionship might be mediated by fetal insulin production.
[27–30]. From the lifecourse perspective, the epistemol-
ogy for the gestational hyperglycemia obesity led epi-
demic has been implied by three important hypotheses.
The ‘fuel mediated teratogenesis’ hypothesis [27, 30]
states that in-utero exposure to maternal hyperglycaemia
can result in fetal hyperinsulinaemia [8, 27, 30–32]. The
‘thrifty phenotype’ hypothesis suggests that adaptive
mechanisms due to child undernutrition may result in
T2DM epidemic in LMICs [4]. The ‘thrifty genotype’
hypothesis infers that conservatory mechanisms at the
level of the genotype can occur in populations that have
undergone a sudden transition from undernutrition to
overnutrition [9]. The ‘thrifty insulin hypothesis’ forms a
part of this, which states that low birth weight and
T2DM are two phenotypes of the same genotype and
also predict insulin resistance [9]. The initial evidence
for these hypotheses is provided by the Parthenon Birth
cohort and similar studies [19, 33–35].
Urbanization-led changes in Indians with contribu-
tions from unique genotype and phenotype is likely con-
tributing to the epidemic of obesity-hyperglycaemia.
India is experiencing a rise in prevalence of adiposity
and glucose intolerance at younger ages, which coincides
with child bearing age for women [30]. The later stages
of the epidemic could then be sustained and augmented
by a feed forward mechanism, through transgenerational
transmission of adiposity and glucose intolerance in
women [36–38]. This presents an opportunity for
exploring a clear strategy for the control of this epidemic
in India through rigorous screening and management of
adiposity and glucose intolerance in pregnancy.
Between November 2013 and May 2015, we conducted
a pilot to inform the design of a large pregnancy cohort
study that could reliably test some aspect of the above-
mentioned hypotheses. The protocol of the initial study
and the baseline results have already been published
[39]. Based on the findings of this pilot, we developed
the protocol for the proposed pregnancy cohort of 5000
women, the recruitment for which began in April 2016.
The protocol of the study documents the processes
which aim at advancing the available knowledge, linking
several steps in the evolution of T2DM.
Methods/design
Aim and objectives
The aim of this study is to prospectively assess the effects
of glucose levels in pregnancy on the risk of adverse infant
outcomes, especially in predicting the possible risk markers
of later chronic diseases (Fig. 1). The primary objective of
the proposed study is to investigate the effect of glucose
levels in pregnancy on skinfold thickness (adiposity) in
infancy as a marker of future obesity and diabetes in off-
spring. Because psychosocial environment could itself be
an important independent predictor of adiposity and could
confound its relationship with maternal hyperglycaemia,
our secondary objective is to assess the association between
psychosocial environment of mothers and adverse neonatal
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outcomes including adiposity. The specific exposure,
outcome and potential confounders for these objectives are
listed in Table 1.
Hypotheses:
1. Maternal glucose in pregnancy is associated with
skinfold thickness (adiposity) of offspring at one year
(Fig. 1)
2. Psychosocial environment measured by social
support and distress is related to skinfold thickness
of offspring at one year (Fig. 2)
For hypotheses 1, the exposure of interest is maternal
blood glucose level. We are not examining gestational
diabetes only, but are interested in exploring the effect
of the continuous range of glucose as exposure from
near normal ranges to hyperglycemia.
After the fasting blood sample is drawn, the pregnant
woman will receive 75 g oral glucose load and a venous
blood sample will be collected 2 hours later for estimat-
ing plasma glucose [40–42]. Evaluation of the samples
will be done through the central laboratory so as to
minimize the confounding effects of analytic variation.
The primary outcome of our study is skinfold thickness
in infants as a measure of adiposity. Skinfold thickness is
the most accurate method of measuring body fat rather
than Body Mass Index (BMI) as this will provide a better
indication of individual fat and risk of obesity. Skinfold
thickness measurement is a traditional and reliable
measure of fat percentage. From research it’s found that
greater weight gain during pregnancy was associated
with higher child’s body mass index, sum of triceps and
subscapular skinfold thickness [43, 44]. The triceps, bi-
ceps and subscapular skinfolds will be measured as
described by Tanner/Whitehouse using a Holtain Cali-
pers (Holtain, U.K.). Triceps skin folds will be measured
over the posterior belly of triceps muscle of the left arm,
halfway between the acromion and the olecranon, on a
line passing upwards from the olecranon in the axis of
the limb, with the arm extended. Subscapular skinfold
will be measured immediately below the angle of the left
scapula, in the natural cleavage line of the skin, with the
arm held by the side of the body. In addition, we will
also assess weight for length and waist girth (in centime-
ters) as co-primary outcomes. Waist girth is measured
by placing the tape around the abdomen immediately
above the umbilicus ensuring that it is horizontal and
marked at the end of expiration. The ultrasound scan re-
cords of the respondents are reviewed and the estimated
foetal weight, biparietal diameter (BPD), head circumfer-
ence (HC), abdominal circumference (AC), femur length
(FL) is recorded. Mother’s weight and skinfold thickness
are measured during antenatal period. Based on the lit-
erature, we have identified the following potential con-
founders based on a priori knowledge: age, BMI, family
Fig. 1 Conceptual Directional Acyclic Graph (DAG) depicting the hypothesis 1. Maternal glucose in pregnancy is associated with skinfold
thickness (adiposity) of offspring at one year
Table 1 The exposure, outcome and potential confounders for the study objectives
Exposure Outcome Potential confounders
Maternal glucose level Skinfold thickness in infants
at one year
Age, body mass index (BMI), family history of diabetes,
gestational age, parity, past medical history, family history
of hypertension and socio-economic status
Psychosocial environment Skinfold thickness in infants
at one year
Maternal age, parity, BMI, weight-gain during pregnancy
on fetal biometry measures, diet, gestational age, lifestyle
factors, alcohol and tobacco use
Babu et al. BMC Pregnancy and Childbirth  (2016) 16:311 Page 3 of 9
history of diabetes, gestational age, parity, past medical
history, family history of hypertension and socio-
economic status.
For hypotheses 2, the exposure of interest is social
support, measured by means of a validated tool (Ques-
tionnaire) administered during second trimester of preg-
nancy. Social support to the mother will be measured
using a questionnaire developed at St. John’s Research
Institute to evaluate a broad range of social support (i.e.,
emotional, instrumental, informational, and appraisal)
[45]. The Edinburgh Postnatal Depression Scale is
administered to the respondents during pregnancy, after
delivery and when the infant is 14 week old. Those who
score greater than 13 in the EPDS scale are administered
Global Mental Health Assessment Tool (GMHAT) for
further diagnosis and are referred to the psychiatrist at
the hospital for counselling and treatment. The outcome
of interest is infant adiposity. The potential confounders
include maternal age, parity, BMI, weight gain during
pregnancy on fetal biometry measures, [46] diet, gestational
age, lifestyle factors, and alcohol and tobacco use [46, 47].
The mother’s 24 hour diet recall is recorded during preg-
nancy. The infant’s feeding mode whether it is breastfed,
time of first breast feed and exclusive breastfeeding at
birth, duration of breastfeeding and complementary
feeding practices for every child is recorded annually. In
addition, we may include additional potential confounders
in the models based on emerging literature.
Sample size and Study centers
Assuming an incidence of 5 % obesity in children born
to mothers with euglycemia, [48, 49] and a relative risk
of 1.5 in the hyperglycaemic group, our estimated sam-
ple size for 80 % power to detect a difference at a 95 %
confidence level, is 2936. Further assuming a loss to
follow-up of up to 60 %, we plan to recruit 5000 women.
The assumed loss to follow up is comparable to another
birth cohort followed up at a similar age in India
(Mysore Parthenon birth cohort); however unlike co-
horts recruited from the community, ours is a hospital
based study with outcome assessment at routine im-
munisation visits during infancy which are generally well
attended, we expect the eventual loss to follow up to be
much lower in our study [50]. We have obtained
approval to conduct the study at Jayanagar General
Hospital, a 300 bedded hospital. In addition, the city
municipal corporation (Brihat Bengaluru Mahanagara
Palike : BBMP) governing the greater Bangalore metro-
politan area has provided approval for public hospitals
in the city to participate in the study. The study is initi-
ated at Jayanagar General Hospital; the hospital registers
around 200–400 new cases of pregnant women each
month.
Eligibility criteria
All pregnant women between the age of 18–45 years
who are less than 32 weeks of gestation and a) plan to
deliver in the study hospital and b) reside in the study
area will be eligible for recruitment. The recruitment
will be done after obtaining an informed consent and
noting relevant socio-demographic details. The exclusion
criteria includes history of diabetes, Hepatitis B infec-
tion, HIV positivity and inability to complete the oral
glucose-tolerance test within 32 weeks of gestation.
Recruitment and follow-up
The process of recruitment, follow-up and corresponding
timelines in the cohort have been captured in the Fig. 3.
Pregnant women with a gestational period of less than
32 weeks will be recruited. A baseline questionnaire will
be administered that includes socio-economic status,
Standard of Living Index, 24-hour dietary recall, dietary
habits, physical activity, obstetrics history, psychosocial
stressors and social support. Weight, height, sitting height,
skinfold thickness of biceps, triceps and subscapular skin-
fold will be recorded (Table 2). Blood pressure will be
Fig. 2 Conceptual Directional Acyclic Graph (DAG) depicting the hypothesis 2. Psychosocial environment measured by social support and distress
is related to skinfold thickness of offspring at one year
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measured using an automated BP apparatus. All
women will undergo an OGTT at 24 to 32 weeks of
gestation. They will be asked to fast for a minimum
8 h prior to the study visit, where fasting samples will
be drawn. Subsequently, 75 g of glucose will be given
and the postprandial sample will be drawn after two
hours. In a sub-sample of pregnant women who have
normal ranges of glucose in the second trimester, an-
other OGTT at 33 to 38 weeks will be performed to
explore the proportion of women who develop gesta-
tional diabetes in the later phase of the third trimes-
ter. In a sub-sample, HbA1c test will also be
conducted based on age, BMI, family history of dia-
betes and parity. Maternal subcutaneous fat is a sig-
nificant predictor of adverse pregnancy outcomes.
The visceral and subcutaneous fat thickness around
abdomen through ultrasound scan will be obtained. A
trained sonographer will be performing the scan and
strict measures will be taken to avoid gender deter-
mination. Visceral fat builds up between and around
internal organs such as the stomach and intestines,
and produces toxins that make the body resistant to
insulin. Subcutaneous fat is found just beneath the
skin, and total fat is the combination of visceral and
subcutaneous fat. Depending on presence in hospital
visits, the husband’s anthropometry and blood pres-
sure will also be recorded.
The measurements on skinfold thickness and weight
for length in infants will be taken at birth and at
14 weeks corresponding to the visit of the mother and
child for the purpose of immunization. These measure-
ments will be repeated once in every year for the
remaining duration of the study. Follow-up at 1, 2, 3 and
4 years will be on the child’s birthday for all children. At
the end of the 4 years of follow up, the glucose and insu-
lin levels in children and mother will be tested (Fig. 3).
Quality control
For questionnaires and anthropometric measurements,
field team will be trained using strict protocols and the
accuracy and interobserver and intraobserver reliability
of their measurements assessed at the outset and every
6 months. Anthropometric equipment will be calibrated
monthly and recordings logged. Biochemical assays car-
ried out by a single laboratory will be quality assured by
India’s National Accreditation Board for Testing and
Calibration Laboratories (NABL). Quality control sam-
ples will be collected for the internal and external quality
checks.
Fig. 3 Flow Diagram depicting the steps in cohort study. The whole process of screening of eligible pregnant women for OGTT, recruitment
and follow-up at the end of 4th year has depicted in this flow diagram
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Data collection
Structured questionnaires will be administered by
trained interviewers for baseline assessment and follow-
up. Data will be entered directly using tablet devices
provided to the field staff with validation checks built in
to minimise data entry errors. Trained phlebotomists
will collect blood samples. Participants not attending
follow-ups will be reminded through linkages with front-
line health workers in the community.
Laboratory analysis and sample storage
We will collect 11 ml fasting venous blood sample and
2 ml postprandial sample 2- h after following a 75 g oral
load of glucose for the laboratory investigations. The
fasting sample will be collected in plain, EDTA and
sodium fluoride vacutainers for storage, haemoglobin
and glucose assays respectively. Blood samples will be
centrifuged and transferred within an hour in cool boxes
to a single central laboratory for assays with external
quality assurance mechanisms in place. Relevant study
assays will be carried out at each time point (Table 3)
and remaining sample stored in aliquots for future
analysis.
Data management and analysis plan
Data analysis
Descriptive analysis will be done to summarize sample
characteristics using frequency and percentage. The
associations of interest for primary and secondary
hypotheses will be assessed using multivariate regression
analyses treating skinfold thickness as a continuous out-
come as obesity is hard to define at this age, with and
without adjustments for potential confounders. For
multivariate analyses, variable selection will be based
Table 2 Anthropometry and ultrasound measurements in
mother and child
Time Test
24–32 weeks Blood pressure of mother (Automatic BP
apparatus)
24–32 weeks Anthropometry of mother
Weight
Height
Sitting Height
Biceps skinfold
Triceps skinfold
Subscapular skinfold
Head circumference
Ultrasound in pregnant
women
Subsample of pregnant women (N = 500):
Visceral and subcutaneous fat thickness
around abdomen.
At birth, 14th week and
then annually
Anthropometry of child
Weight
Length
Crown rump length
Head circumference
Chest circumference
Waist circumference
Hip circumference
Biceps skinfold
Triceps skinfold
Subscapular skinfold
Table 3 List of laboratory tests, sample size and proposed biomarkers in the study
Time/Sample Test N Biomarker
Pregnant women
between 24–32 weeks
Blood pressure (automated) 5000
OGTT (Fasting plasma glucose, 2 Hour Postprandial
plasma glucose)
5000 Glucose
Haemoglobin 5000 Haemoglobin
HbA1c (glycosylated haemoglobin, Type A1C) 500 Glycosylated haemoglobin
One aliquot of fasting sample will be frozen at −80 °C
for measurement of serum insulin
1000 Insulin resistance and insulin secretion through
homeostasis model assessment (HOMA)
Blood sample to be preserved at−800 C 5000 Micronutrients, DNA and protein markers
Repeat OGTT after 32 weeks (Fasting plasma glucose, 2
Hour Postprandial plasma glucose)
500 To explore those who develop gestational diabetes
after 32 weeks
Cord blood C-peptide 100 Insulin
Fathers Fasting blood glucose in fathers 500 Glucose
Mothers (During follow
up visits)
Random blood glucose 5000 Glucose
At the end of the study
(IV year)
Fasting blood glucose and insulin levels in mother
and child
5000 Glucose
Babu et al. BMC Pregnancy and Childbirth  (2016) 16:311 Page 6 of 9
primarily on prior knowledge (a priori) and also the out-
come of crude analysis. Variables with p-values > 0.10 in
the univariate analysis will be included in the multivari-
ate analysis. Possible interactions will also be explored
by including product terms in the model [51]. For
continuous-variable analyses, odds ratios will be calcu-
lated for a 1-SD increase in fasting and 2-h plasma glu-
cose levels. Sum of skin folds >90th percentile will be
determined for term deliveries based on gender with
adjustment for gestational age and parity (0, 1, and 2+).
A detailed plan for data analysis is provided in the
Additional file 1.
Discussion
The findings from this study may help to address im-
portant questions on screening and management of high
blood sugar in pregnancy. It may provide critical infor-
mation on the specific determinants driving the
underweight-obesity-T2DM epidemic in India, particu-
larly when the data is considered together with data
from other cohorts such as the Mysore Parthenon Study,
which collected data when India was at an earlier stage
of its nutrition transition. In addition it may provide
data on appropriate values of cut-offs for healthy glucose
levels in pregnancy in India, as well as explorations of
role of maternal nutritional status, confounding by psy-
chosocial environment and other determinants.
There can be significant public health implications of
the study. First, due to implementation in public health
facilities, the results could directly inform the potential
impact of scaling up stronger screening and manage-
ment protocols in the future. Second, the results can
position the issues of maternal glycemic control and
weight management (both underweight and obesity) to
the core of policy agenda. Third, the results may suggest
lifestyle modifications in both women and children to
prevent and postpone the development of T2DM.
Additional file
Additional file 1: A detailed plan for data analysis. Conceptual DAG for
data analysis and Model-based analysis. (DOCX 133 kb)
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